BRPI0519624B8 - processo para preparação de ansamitocinas purificadas - Google Patents

processo para preparação de ansamitocinas purificadas

Info

Publication number
BRPI0519624B8
BRPI0519624B8 BRPI0519624A BRPI0519624A BRPI0519624B8 BR PI0519624 B8 BRPI0519624 B8 BR PI0519624B8 BR PI0519624 A BRPI0519624 A BR PI0519624A BR PI0519624 A BRPI0519624 A BR PI0519624A BR PI0519624 B8 BRPI0519624 B8 BR PI0519624B8
Authority
BR
Brazil
Prior art keywords
ansamitocins
preparing purified
purified ansamitocins
preparing
purify
Prior art date
Application number
BRPI0519624A
Other languages
English (en)
Portuguese (pt)
Inventor
Kuo Cynthia
S Byng Graham
C Widdison Wayne
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36692550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0519624(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of BRPI0519624A2 publication Critical patent/BRPI0519624A2/pt
Publication of BRPI0519624B1 publication Critical patent/BRPI0519624B1/pt
Publication of BRPI0519624B8 publication Critical patent/BRPI0519624B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0519624A 2005-01-19 2005-12-12 processo para preparação de ansamitocinas purificadas BRPI0519624B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/037,104 US7432088B2 (en) 2003-05-08 2005-01-19 Methods for the production of ansamitocins
US11/037,104 2005-01-19
PCT/US2005/044783 WO2006078368A1 (en) 2005-01-19 2005-12-12 Methods for the production of ansamitocins

Publications (3)

Publication Number Publication Date
BRPI0519624A2 BRPI0519624A2 (pt) 2009-02-25
BRPI0519624B1 BRPI0519624B1 (pt) 2021-01-19
BRPI0519624B8 true BRPI0519624B8 (pt) 2021-05-25

Family

ID=36692550

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519624A BRPI0519624B8 (pt) 2005-01-19 2005-12-12 processo para preparação de ansamitocinas purificadas

Country Status (27)

Country Link
US (1) US7432088B2 (enExample)
EP (2) EP2514828B1 (enExample)
JP (1) JP5106120B2 (enExample)
KR (3) KR20120099734A (enExample)
CN (2) CN101103120A (enExample)
AU (1) AU2005325166B2 (enExample)
BR (1) BRPI0519624B8 (enExample)
CA (2) CA2595024C (enExample)
CR (1) CR9228A (enExample)
CY (1) CY1121372T1 (enExample)
DK (1) DK2514828T3 (enExample)
EA (1) EA012524B1 (enExample)
ES (1) ES2710875T3 (enExample)
HK (1) HK1211985A1 (enExample)
HU (1) HUE042312T2 (enExample)
IL (2) IL183918A (enExample)
LT (1) LT2514828T (enExample)
MX (1) MX2007008069A (enExample)
NO (1) NO342876B1 (enExample)
NZ (2) NZ583446A (enExample)
PL (1) PL2514828T3 (enExample)
PT (1) PT2514828T (enExample)
SG (1) SG158905A1 (enExample)
SI (1) SI2514828T1 (enExample)
TR (1) TR201901647T4 (enExample)
WO (1) WO2006078368A1 (enExample)
ZA (1) ZA200704918B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE446317T1 (de) 2001-05-11 2009-11-15 Ludwig Inst For Cancer Res Ltd Spezifische bindungsproteine und ihre verwendung
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
WO2007044576A1 (en) * 2005-10-07 2007-04-19 Steward Environmental Solutions, Llc Method to remove an agent using a magnetic carrier
US20070135629A1 (en) * 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Isolation of ansamitocins
EP2046470A2 (en) * 2006-07-10 2009-04-15 Sicor, Inc. Apparatus for the separation of a resin from a reaction mixture
CN100420754C (zh) * 2006-10-26 2008-09-24 浙江海正药业股份有限公司 一种制备蒽莎姆菌素的方法
CN101711284A (zh) 2007-01-25 2010-05-19 达娜-法勃肿瘤研究所 抗egfr抗体在治疗egfr突变体介导的疾病中的用途
ES2542152T3 (es) 2007-03-15 2015-07-31 Ludwig Institute For Cancer Research Ltd. Método de tratamiento que emplea anticuerpos de EGFR e inhibidores de Src y formulaciones relacionadas
JP5469600B2 (ja) 2007-07-16 2014-04-16 ジェネンテック， インコーポレイテッド 抗ＣＤ７９ｂ抗体及びイムノコンジュゲートとその使用方法
SG183044A1 (en) 2007-07-16 2012-08-30 Genentech Inc Humanized anti-cd79b antibodies and immunoconjugatesand methods of use
WO2009023265A1 (en) 2007-08-14 2009-02-19 Ludwig Institute For Cancer Research Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof
UA106586C2 (uk) 2008-01-31 2014-09-25 Дженентек, Інк. Анти-cd79b антитіла, і імунокон'югати та способи їх застосування
KR20160125535A (ko) 2008-03-18 2016-10-31 제넨테크, 인크. 항-ｈｅｒ２ 항체-약물 접합체와 화학요법제의 병용물, 및 사용 방법
CN101319241B (zh) * 2008-07-17 2011-03-30 上海交通大学 安丝菌素的固体发酵方法
BRPI1012676A2 (pt) 2009-04-01 2016-04-05 Genentech Inc anticorpos anti-fcrh5 e imunoconjugados e métodos de uso
AR079256A1 (es) 2009-12-04 2012-01-04 Genentech Inc Metodo para el tratamiento del cancer de mama metastasico con trastuzumab-mcc-dm1
CN101921817A (zh) * 2010-09-07 2010-12-22 上海交通大学 安莎霉素发酵产量提高方法
CA2816426A1 (en) 2010-11-17 2012-06-07 Genentech, Inc. Alaninyl maytansinol antibody conjugates
US8852435B2 (en) * 2011-11-29 2014-10-07 Therapeutics Proteins International, LLC Purification and separation treatment assembly (PASTA) for biological products
CN103255184B (zh) * 2012-02-15 2016-01-27 百奥泰生物科技(广州)有限公司 生产安丝菌素的发酵培养基
CN103805648B (zh) * 2012-11-13 2017-09-15 百奥泰生物科技(广州)有限公司 高产安丝菌素发酵工艺
US10208125B2 (en) 2013-07-15 2019-02-19 University of Pittsburgh—of the Commonwealth System of Higher Education Anti-mucin 1 binding agents and uses thereof
TWI541022B (zh) 2013-12-18 2016-07-11 應克隆公司 針對纖維母細胞生長因子受體－３（ｆｇｆｒ３）之化合物及治療方法
TW201711702A (zh) 2015-06-04 2017-04-01 應克隆公司 使用針對纖維母細胞生長因子受體３（ｆｇｆｒ３）之化合物的療法
CN113607945B (zh) 2015-07-07 2025-01-28 豪夫迈·罗氏有限公司 抗HER2抗体-药物缀合物和Bcl-2抑制剂的组合疗法
CN105907681B (zh) * 2016-05-30 2019-11-19 苏州康聚生物科技有限公司 一种高产安丝菌素p-3的突变株及安丝菌素p-3的制备方法
CN110234348B (zh) 2016-12-16 2024-06-25 蓝鳍生物医药公司 抗-含cub结构域蛋白1(cdcp1)抗体、抗体药物缀合物及其使用方法
CN108276427A (zh) * 2018-01-14 2018-07-13 常州大学 一种安丝菌素p-3的提取与分离纯化方法
CN108330113B (zh) * 2018-03-08 2019-05-28 山东省医药生物技术研究中心（山东省病毒研究所） 一株高底物专一性酰基转移酶的珍贵束丝放线菌及其应用
CN113444106A (zh) * 2020-03-25 2021-09-28 重庆乾泰生物医药有限公司 一种高纯度安丝菌素的制备方法
CN112630368A (zh) * 2020-12-18 2021-04-09 卓和药业集团有限公司 安丝菌素含量的高效液相色谱检测分析方法
CN117597450A (zh) * 2021-06-18 2024-02-23 杭州中美华东制药有限公司 安丝菌素p-3的提纯方法
CN115477658A (zh) * 2022-10-12 2022-12-16 道中道（菏泽）制药有限公司 一种有效降低安丝菌素p-3杂质的结晶方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2241418A1 (de) 1972-08-23 1974-03-07 S Morris Kupchan Antileukaemische ansamakrolide
US4162940A (en) 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia
JPS53130495A (en) * 1977-04-01 1978-11-14 Takeda Chem Ind Ltd Antibiotic substance c-15003
JPS6034556B2 (ja) * 1977-03-31 1985-08-09 武田薬品工業株式会社 抗生物質ｃ−１５００３
JPS6010718B2 (ja) 1977-03-31 1985-03-19 武田薬品工業株式会社 メイタンシノ−ル，メイタナシンおよびメイタンシノ−ル・プロピオネ−トの製造法
JPS53124692A (en) 1977-04-01 1978-10-31 Takeda Chem Ind Ltd Preparation of maytansinol, maytansine, and maytansinol, propionate
US4151042A (en) * 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
US4137230A (en) 1977-11-14 1979-01-30 Takeda Chemical Industries, Ltd. Method for the production of maytansinoids
JPS6016236B2 (ja) 1977-11-18 1985-04-24 武田薬品工業株式会社 抗生物質ｃ―１５００３ ｐ―３の製造法
US4307016A (en) * 1978-03-24 1981-12-22 Takeda Chemical Industries, Ltd. Demethyl maytansinoids
JPS5529972A (en) 1978-08-24 1980-03-03 Takeda Chem Ind Ltd Preparation of maytansinol
JPS55102583A (en) * 1979-01-31 1980-08-05 Takeda Chem Ind Ltd 20-acyloxy-20-demethylmaytansinoid compound
JPS55162791A (en) * 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JPS56102793A (en) * 1979-12-28 1981-08-17 Takeda Chem Ind Ltd Preparation of antibiotic c-15003 p-3
JPS57192389A (en) * 1981-05-20 1982-11-26 Takeda Chem Ind Ltd Novel maytansinoid
CA2006408A1 (en) 1988-12-27 1990-06-27 Susumu Iwasa Bispecific monoclonal antibody, its production and use
US5208020A (en) * 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
DE10012120A1 (de) 2000-03-13 2001-09-27 Ktb Tumorforschungs Gmbh Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel
US6573074B2 (en) * 2000-04-12 2003-06-03 Smithkline Beecham Plc Methods for ansamitocin production
WO2001095943A2 (en) 2000-06-14 2001-12-20 Medarex, Inc. Prodrug compounds with an oligopeptide having an isoleucine residue
US6333410B1 (en) * 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
US20020156274A1 (en) * 2001-03-16 2002-10-24 Terfloth Gerald J. Process for preparing maytansinol
US6441163B1 (en) * 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
US6790954B2 (en) * 2002-01-29 2004-09-14 Immunogen, Inc. Mutant Actinosynnema pretiosum strain with increased maytansinoid production
WO2005020883A2 (en) * 2003-05-08 2005-03-10 Immunogen, Inc. Methods for the production of ansamitocins
US7276497B2 (en) * 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids

Also Published As

Publication number Publication date
EP2514828A3 (en) 2013-07-03
ZA200704918B (en) 2008-11-26
CA2595024A1 (en) 2006-07-27
HUE042312T2 (hu) 2019-06-28
EA012524B1 (ru) 2009-10-30
CA2834033A1 (en) 2006-07-27
JP2008526267A (ja) 2008-07-24
JP5106120B2 (ja) 2012-12-26
PT2514828T (pt) 2019-02-15
NO342876B1 (no) 2018-08-20
IL183918A0 (en) 2007-10-31
BRPI0519624B1 (pt) 2021-01-19
CN104745655A (zh) 2015-07-01
CN101103120A (zh) 2008-01-09
CR9228A (es) 2008-03-31
TR201901647T4 (tr) 2019-02-21
KR20120099734A (ko) 2012-09-11
DK2514828T3 (en) 2019-03-11
AU2005325166B2 (en) 2012-02-02
MX2007008069A (es) 2007-08-21
CY1121372T1 (el) 2020-05-29
PL2514828T3 (pl) 2019-04-30
CA2595024C (en) 2014-02-04
SI2514828T1 (sl) 2019-03-29
WO2006078368A1 (en) 2006-07-27
HK1211985A1 (en) 2016-06-03
LT2514828T (lt) 2019-02-25
KR20130051019A (ko) 2013-05-16
ES2710875T3 (es) 2019-04-29
EP1838863A1 (en) 2007-10-03
IL215686A0 (en) 2011-11-30
CA2834033C (en) 2017-01-24
KR20070099576A (ko) 2007-10-09
EP2514828A2 (en) 2012-10-24
EP1838863A4 (en) 2011-10-05
EA200701310A1 (ru) 2008-06-30
US7432088B2 (en) 2008-10-07
NO20074222L (no) 2007-10-18
KR101515873B1 (ko) 2015-04-29
IL183918A (en) 2013-07-31
NZ555437A (en) 2010-04-30
IL215686A (en) 2013-07-31
BRPI0519624A2 (pt) 2009-02-25
AU2005325166A1 (en) 2006-07-27
NZ583446A (en) 2011-08-26
EP2514828B1 (en) 2018-11-14
SG158905A1 (en) 2010-02-26
US20050170475A1 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
BRPI0519624B8 (pt) processo para preparação de ansamitocinas purificadas
MY201120A (en) Intermediates for use in a process of producing pyrrole compounds
FI20115722A0 (fi) Menetelmä ja laite biologista alkuperää olevan materiaalin puhdistamiseksi
MX2012003048A (es) Procesos para preparar derivados de bencil-benceno sustituidos con glucopiranosilo.
BRPI0517093B8 (pt) processo para a produção de 8-(3-amino-piperidin-1-il)-xantinas quirais
ATE469233T1 (de) Herstellungsverfahren für optisch aktive chirale amine
BRPI0804592A2 (pt) produto contìnuo graxo aerado e processo para a produção de um produto contìnuo graxo aerado
BR112012001078A8 (pt) Processo para preparação de derivados de sulfóxido de 3-triazolila quirais
BR112012019406A2 (pt) processo para purificacao de um produto de etanol bruto
NZ586187A (en) Processes for the synthesis of sinomenine derivatives and their intermediate
BR112013026660A2 (pt) métodos ou processos para produção de depsipeptídeos macrocíclicos e intermediários
BR112014014762A8 (pt) método para preparação de cisteína ou de um derivado desta usando uma nova o-fosferina sulfidrilase
BRPI0814126A2 (pt) Processo para a preparação de drospirenona
WO2010058427A3 (en) Process for production and purification of polymyxin b sulfate
EP2351712A4 (en) METHOD FOR PRODUCING SYNTHETIC QUARTZ GLASS
EP2311971A4 (en) PROCESS FOR THE PREPARATION OF HYALURONIC ACID
UY32195A (es) Proceso para la preparación benzonorborenenos
BR112014010715A2 (pt) produção microbial de n-butiraldeído
WO2009076948A3 (de) Reduktone zur erzeugung von biogas
MY155962A (en) Photochemical process for producing artemisinin
BRPI0909327A2 (pt) Processo para a produção de gás de síntese
BR112012011680A2 (pt) processo para a produção de silício
NZ596060A (en) NOVEL CRYSTAL FORMS OF TRICYCLIC BENZOPYRAN COMPOUND AND PROCESSES FOR PRODUCING SAME; (3R,4S)-7-hydroxymethyl-2,2,9-trimethyl-4-(phenethylamino)-3,4-dihydro-2H-pyrano[2,3g]quinolin-3-ol
ATE538102T1 (de) Verfahren zur herstellung eines chinazolinderivats
BRPI0603912A (pt) processo para produção de acetais, acetais e seus usos

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2153 DE 10/04/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B25G Requested change of headquarter approved

Owner name: IMMUNOGEN, INC. (US)

Free format text: ENDERECO DO DEPOSITANTE ALTERADO CONFORME SOLICITADO NA PETICAO NO 020110101858/RJ DE 30/09/2011.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/12/2005 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF